About
Eurofins Discovery provides drug discovery services and products for pharmaceutical, biotechnology, and other research organizations. It supports discovery and development across small molecules, biotherapeutics, integrated drug discovery programs, therapeutic areas, and research phases from global locations including Spain, the US, and India.
Services
Small Molecules
Supports preclinical small molecule programs with target identification, hit finding, lead optimization, mechanistic studies, and preclinical safety and toxicity assessments.
Assays & in vitro testing
Biotherapeutics
Supports biologics discovery and development from target validation and antigen generation through manufacturability assessment, immunogenicity testing, and preclinical development.
Assays & in vitro testing
Integrated Drug Discovery
Provides an integrated program combining chemistry, biology, ADME, pharmacology, and project management through DiscoveryOne.
Assays & in vitro testing
Therapeutic Areas
Develops assays and models tailored to specific disease areas such as cardiovascular disease, MASH and diabetes, fibrosis, infectious diseases, inflammation, immunology, metabolic disorders, neuroscience, oncology, and orphan diseases.
Assays & in vitro testing
Research Phase
Offers phase-specific assays and services from basic research through target ID and validation, hit finding, hit-to-lead, lead optimization, and pre-clinical candidate selection.
Assays & in vitro testing
Custom Solutions
Modifies and customizes assays and related workflows for small molecule and biotherapeutics discovery needs.
Assays & in vitro testing
LeadHunter target-based assays
Offers off-the-shelf assays against challenging targets for target-based drug discovery.
Assays & in vitro testing
GPCRs
Provides G-protein coupled receptor assays for discovery and screening.
Assays & in vitro testing
22 more services
- Kinases
- Ion Channels
- Chemistry services
- Translational Biology
- Safety Pharmacology
- ADME Toxicology
- Assay Kits & Reagents
- Cell-based assay products
- Cell Lines & Primary Cells
- Detection Kits & Reagents
- Recombinant Proteins & Kinases
- Bioassays for Biologics
- Membrane Preparations
- Assay Development
- Protein Science
- Proteomics
- Cell Line Development & Banking
- DiscoveryOne project management
- In Vivo Pharmacology
- Targeted Protein Degradation
- AI-Driven Drug Discovery
- Target Validation and Antigen Generation
Capabilities
- Assays and studies
- Small molecules
- Antibodies
- In vivo
- ADME
- ADCs
- Cell-based assays
23 more
- Immunogenicity
- Cell therapy
- Toxicology
- Flow cytometry
- Biochemical assays
- Biophysical characterization
- SPR
- Functional assays
- Translational assays
- In vitro assays
- In vivo assays
- Target-based assays
- Phenotypic assays
- Enzyme assays
- Radiolabel binding assays
- MS binding assays
- Immunogenicity testing
- Safety assays
- Safety pharmacology assays
- ADME assays
- Immunogenicity assays
- DAR analysis
- Kinase selectivity profiling
- Scale and capacity
- Over 23,000 services and products
- Over 10,000 assays
- Over 600 ADME/toxicology assays
- Over 100 validated infection models
- 850+ MIC characterized strains
- Over +10,000 assays
5 more
- Over 600 assays
- More than 100 validated infection models
- 850+ MIC characterized strains and MDR clinical isolates
- Over 40 INDs
- Five commercially approved drugs
- Therapeutic areas
- Cardiovascular disease
- MASH
- Diabetes
- Fibrosis
- Infectious diseases
- Inflammation
12 more
- Immunology
- Metabolic disorders
- Neuroscience
- Pain
- Neurodegenerative diseases
- Oncology
- Immuno-oncology
- Orphan diseases
- CNS disorders
- Obesity
- Renal disorders
- Respiratory diseases
Instruments and platforms
- SPR
- Flow cytometry
Modalities and species
- Modalities
- Small molecule
- Antibody
- ADC
- Peptide
- mRNA
- Viral vector
3 more
- Cell therapy
- Recombinant protein
- Vaccine
- Species and models
- Human primary cells
- iPSC-derived cardiomyocytes
- Rodent models
- Human disease models
- In vivo animal models
- Cell lines
3 more
- MDR clinical isolates
- 850+ MIC characterized strains
- SARS-CoV-2
Certifications
As the company states them, with the certificate or registry record where there is one.
GLPSelf-reported
Details
- Type
- CRO
- Founded
- 1987
- Quality
- Quality Assurance/Quality Control (QA/QC
- Sites
- Spain
- US
- India
- Serves
- Global